Genenta Science (GNTA) director reports no share or ADS ownership

Rhea-AI Filing Summary

Genenta Science S.p.A. director Giacomoantonio Paracchi has filed an initial Form 3 ownership report indicating that he does not currently own any ordinary shares, American Depositary Shares, or derivative securities of the company. Each American Depositary Share represents one ordinary share with no par value.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider PARACCHI GIACOMOANTONIO

Role Director

Type	Security	Shares	Price	Value
holding	Ordinary Shares	--	--	--
holding	American Depositary Shares ("ADSs")	--	--	--

Holdings After Transaction: Ordinary Shares — 0 shares (Direct); American Depositary Shares ("ADSs") — 0 shares (Direct)

Footnotes (2)

1. F1. Mr. G. Paracchi does not currently own any shares or derivatives in Genenta Science S.p.A.
2. F2. Each American Depositary Share represents one ordinary share, no par value, of the Issuer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Accepted by SEC EDGAR 03/25/2026 - 04:39 PM Learn about SEC filing dates

FAQ

What does Genenta Science (GNTA) disclose in this Form 3 for Giacomoantonio Paracchi?

The Form 3 shows that director Giacomoantonio Paracchi currently holds no ordinary shares, American Depositary Shares, or derivative securities of Genenta Science S.p.A. It serves as his initial beneficial ownership statement as a company insider.

Does Genenta Science (GNTA) director Giacomoantonio Paracchi own any GNTA shares?

According to the Form 3, Giacomoantonio Paracchi does not currently own any Genenta Science ordinary shares, ADSs, or derivative securities. The footnote explicitly states that he has no share or derivative ownership in the company at this time.

What are American Depositary Shares (ADSs) for Genenta Science (GNTA)?

For Genenta Science, each American Depositary Share represents one ordinary share with no par value. ADSs allow investors to hold an interest in the company’s ordinary shares through a U.S.-traded instrument with a one-to-one share relationship.

Are there any buy or sell transactions reported for GNTA in this Form 3?

No buy or sell transactions are reported. The Form 3 only reflects holding entries with zero shares and a footnote confirming that Giacomoantonio Paracchi currently owns no Genenta Science shares or derivatives, so there is no trading activity disclosed.

Why is Genenta Science (GNTA) filing an initial Form 3 for its director?

Form 3 is required when someone becomes an insider, such as a director. Genenta Science’s Form 3 for Giacomoantonio Paracchi records his initial beneficial ownership position, which is currently zero shares and zero derivatives in the company’s securities.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

PARACCHI GIACOMOANTONIO

(Last) (First) (Middle)

VIA REPUBBLICA 17

(Street)

NOVATE MILANESE, 20026

(City) (State) (Zip)

ITALY

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Genenta Science S.p.A. [ GNTA ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares(1)	0	D
American Depositary Shares ("ADSs")(2)	0	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Mr. G. Paracchi does not currently own any shares or derivatives in Genenta Science S.p.A.

2. Each American Depositary Share represents one ordinary share, no par value, of the Issuer.

	/s/ Giacomoantonio Paracchi	03/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)